Scoop has an Ethical Paywall
Licence needed for work use Learn More
 

AFT Pharmaceuticals - Latest News [Page 1]

AFT Agrees Distribution For Crystaderm In China

Tuesday, 9 July 2024, 9:29 am | AFT Pharmaceuticals

AFT Pharmaceuticals (NZX: AFT, ASX: AFP) today announces an agreement with Hainan Haiyao Co. Ltd (Shenzhen Stock Exchange SZ:000566) to distribute Crystaderm® cream in China, the second largest pharma market in the world*. More >>

AFT Finalises Refinancing And Gives Trading Update

Monday, 23 March 2020, 11:03 am | AFT Pharmaceuticals

AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today announces it has concluded an agreement with the Bank of New Zealand (BNZ) to refinance its current six-year CRG loan facility maturing on 31 March 2020. This follows the term sheet concluded with the BNZ which ... More >>

AFT welcomes new codeine medicine restrictions

Thursday, 5 December 2019, 9:41 am | AFT Pharmaceuticals

AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today welcomes Medsafe’s decision to classify all medicines containing codeine as prescription medicines. More >>

AFT and SETEK sign medicinal cannabis MoU

Tuesday, 8 October 2019, 9:08 am | AFT Pharmaceuticals

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) and New Zealand medicinal cannabis company SETEK today announce they have signed a memorandum of understanding (MoU) to work together in the research, development and commercialisation of medicinal cannabis ... More >>

AFT Pharmaceuticals completes first deal in South America

Thursday, 20 June 2019, 2:00 pm | AFT Pharmaceuticals

AFT Pharmaceuticals’ completes first deal in South America AFT signs Maxigesic® Licensing Agreement with Barcelona-based Galenicum Vitae S.L.U for Colombia, Peru and Chile. More >>

AFT Pharmaceuticals establishes new borrowing facilities

Wednesday, 22 May 2019, 11:36 am | AFT Pharmaceuticals

AFT Pharmaceuticals (AFT) today announces it has established a NZ$15 million interim banking facility with the BNZ, enabling the company to commence refinancing its borrowings at more attractive rates. The new facility uses the existing security arrangements ... More >>

AFT Pharmaceuticals on track to return to profitability

Thursday, 22 November 2018, 9:28 am | AFT Pharmaceuticals

AFT Pharmaceuticals, manufacturer of the Maxigesic painkiller, significantly shrunk its first half loss to $0.1million from $6.7 million in the prior period, saying it remains on track to return to profitability in this financial year. More >>

Prescription-only codeine medicines in New Zealand welcomed

Thursday, 18 January 2018, 12:13 pm | AFT Pharmaceuticals

Prescription-only codeine medicines in New Zealand welcomed Yesterday the Medicines Classification Committee announced its recommendation that all codeine combination medicines, both analgesics and those used for cough and colds, should be up-scheduled ... More >>

AFT Pharmaceuticals celebrates 20 years of success

Friday, 1 September 2017, 10:08 am | AFT Pharmaceuticals

Twenty years ago this week, husband and wife Dr Hartley Atkinson and Marree Atkinson, started AFT Pharmaceuticals (AFT) in a room off their home garage. More >>

Maxigesic now licensed in 124 countries worldwide

Thursday, 20 July 2017, 12:52 pm | AFT Pharmaceuticals

AFT Pharmaceutical’s painkiller Maxigesic now licensed in 124 countries worldwide AFT Pharmaceuticals (‘AFT’) has added to its existing agreements in concluding an alliance with a private European pharmaceutical company, Amicus SA Switzerland ... More >>

AFT Pharmaceuticals In-Licenses NovaTears® in Australia & NZ

Tuesday, 21 March 2017, 11:37 am | AFT Pharmaceuticals

AFT Pharmaceuticals (AFT) has completed a licensing agreement with Novaliq, a German specialty pharmaceutical company, to distribute NovaTears® in Australia and New Zealand. More >>

TGA decision will boost Maxigesic sales in Australia

Tuesday, 20 December 2016, 11:33 am | AFT Pharmaceuticals

The Australian Therapeutic Goods Administration has today confirmed an interim decision that all medicines containing codeine be rescheduled to prescription-only medicines effective 1 February 2018. More >>

We all need to play our part in reducing antibiotic use

Tuesday, 22 November 2016, 11:18 am | AFT Pharmaceuticals

Managing Director of AFT Pharmaceuticals, Dr Hartley Atkinson, says that the pharmaceutical industry needs to take a leading role in helping reduce antibiotic use. More >>

New agreement for AFT Pharmaceuticals with Belgian Pharma

Friday, 23 September 2016, 11:39 am | AFT Pharmaceuticals

AFT Pharmaceuticals (‘AFT’) has executed an alliance agreement with privately-owned pharmaceutical company, Therabel Pharma NV (‘Therabel’), to license the product line of its patented combination painkiller, Maxigesic, to Belgium and Luxembourg. More >>

AFT Pharmaceuticals strengthens Asian operations

Tuesday, 10 May 2016, 11:32 am | AFT Pharmaceuticals

AFT Pharmaceuticals (AFT) is continuing to build its business operations in South East Asia by moving to the appointment of a Business Manager based in its Kuala Lumpur office in Malaysia. More >>

Maxigesic to carry Gold Cross logo

Friday, 18 March 2016, 11:12 am | AFT Pharmaceuticals

Australia and New Zealand pharmaceutical company, AFT Pharmaceuticals, has today announced that specific 24 tablet packets of its Maxigesic analgesic will soon carry the Pharmacy Guild of Australia’s ‘Gold Cross’ logo. More >>

AFT Pharmaceuticals lists on the NZX Main Board and ASX

Tuesday, 22 December 2015, 2:17 pm | AFT Pharmaceuticals

Shares in AFT Pharmaceuticals Limited (“AFT”), began trading on the NZX Main Board and ASX today following the successful IPO that raised $35.6 million through the issue and sale of new and existing shares. More >>

AFT Pharmaceuticals considering an IPO

Friday, 9 October 2015, 10:02 am | AFT Pharmaceuticals

AFT Pharmaceuticals considering an IPO to accelerate international growth \ Growing New Zealand and Australia based multinational pharmaceutical company, AFT Pharmaceuticals, has announced today that it is considering an initial public offering and listing ... More >>

Further US investment in AFT Pharmaceuticals

Thursday, 28 May 2015, 9:23 am | AFT Pharmaceuticals

Specialty Australasian pharmaceutical sales and development company, AFT Pharmaceuticals Ltd (AFT), has finalised a follow-on equity capital raise with CRG (formerly Capital Royalty L.P.), Atkinson family, AFT board members, and a group of specialist pharma ... More >>

Doctors have alternatives to topical treatments

Thursday, 19 March 2015, 1:13 pm | AFT Pharmaceuticals

Infectious disease experts this week drew attention to the growing link between topical antibiotic treaments in New Zealand and the superbug MRSA. More >>

 

 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.